PSA ELISA
Mexico·Clase I·III. DIAGNOSTIC AGENTS·INVESTIGACIÓN DIAGNÓSTICA, S.A. DE C.V.·Registered February 23, 2018ANÁLISIS ELISA PARA LA DETERMINACIÓN CUANTITATIVA DEL ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA) TOTAL EN SUERO HUMANO. EL ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA) ES UNA GLICOPROTEÍNA (SERINA PROTEASA), SINTETIZADA POR LAS CÉLULAS EPITELIALES PROSTÁTICAS. LOS V
ELISA ANALYSIS FOR THE QUANTITATIVE DETERMINATION OF TOTAL PROSTATE-SPECIFIC ANTIGEN (PSA) IN HUMAN SERUM. PROSTATE-SPECIFIC ANTIGEN (PSA) IS A GLYCOPROTEIN (SERINE PROTEASE), SYNTHESIZED BY PROSTATIC EPITHELIAL CELLS. THE V
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVOS PARA DETERMINAR ANTÍGENO PROSTÁTICO ESPECÍFICO
- Trade Name (English)
- REAGENTS TO DETERMINE PROSTATE-SPECIFIC ANTIGEN
- Analysis ID
- 522R2018 SSA
- Registration Date
- February 23, 2018
- Name (Spanish)
- INVESTIGACIÓN DIAGNÓSTICA, S.A. DE C.V.
- Name (English)
- INVESTIGACIÓN DIAGNÓSTICA, S.A. DE C.V.
Access comprehensive regulatory information for PSA ELISA (PSA ELISA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 522R2018 SSA and manufactured by INVESTIGACIÓN DIAGNÓSTICA, S.A. DE C.V.. The device was registered on February 23, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.